EXHIBIT 99.1
PRESS RELEASE ISSUED JUNE 1, 2000
<PAGE>
CONTACT:
Karen Miller
Vice President Finance and CFO
(703) 847-1400 ext. 131
APACHE MEDICAL NAMES
NEW PRESIDENT AND CEO
McLean, VA - June 1, 2000 - APACHE Medical Systems, Inc. today announced that
William A. Knaus, M.D., founder, a current director as well as the Company's
Chief Scientific Advisor, will become President and Chief Executive Officer of
APACHE, effective July 1, 2000. Peter Gladkin, APACHE's current president and
chief executive officer, in accordance with the conclusion of his employment
contract, will step down on that date from those positions and as a Director of
the Company.
Thomas W. Hodson, APACHE's Chairman said, "Peter Gladkin has provided the
Company with considerable expertise in implementing long-term management
improvements, controlling its costs and launching our internet strategy during
his tenure with APACHE. Having accomplished these key objectives, the Company
is now ready to move into a new stage of development and growth under the
leadership of Bill Knaus, while maintaining the operating discipline that Peter
brought to the company."
Knaus is the Evelyn Troup Hobson Professor and founding Chair of the Department
of Health Evaluation Sciences at the University of Virginia in Charlottesville,
Virginia. He has held those positions since October 1995 and has successfully
designed and developed this new clinical department into both an academic and
financial success for the University.
"APACHE Medical Systems is the recognized leader in the development and efficacy
of risk-adjusted models, clinical decision support and quality improvement
programs for the care of high-risk, high-cost patients," Hodson continued.
"Bill Knaus is recognized as the leading developer of the APACHE prognostic
scoring system methodology and we are indeed fortunate to be able to draw more
directly on Bill's vision and his fundamental passion for the advancement of
health care through using data driven decision tools to improve both quality and
health care outcomes."
Hodson added, "Throughout Bill's distinguished professional career, he has
consistently managed high caliber people within complex organizations and we
look forward to Bill providing a strong strategic direction for APACHE going
forward."
Hodson further said, "Peter Gladkin has done an excellent job of strengthening
the APACHE management team and establishing the platform for shifting APACHE's
clinical applications to the Internet. He and the APACHE team successfully
navigated through the Y2K challenges of APACHE's clients and, most importantly,
improved the quality of APACHE's balance sheet during the period of his
leadership."
APACHE Medical Systems, Inc. -- a recognized leader in clinical decision
support/outcomes management systems and consulting services for the care of
high-risk patients--provides products and services that enable health systems,
hospitals and providers to apply an evidence-based approach to achieve clinical
performance excellence, reduce cost and compete effectively under managed care.
APACHE is helping providers better manage the clinical, financial and patient
outcomes of high-risk, high-cost patients in critical, acute, cardiovascular and
HIV/AIDS care. One of the most experienced healthcare consultancies in the
U.S., APACHE/National Health Advisors is nationally known for its work in the
field of integrated delivery system development. Its comprehensive suite of
services includes strategic planning, clinical service line management, service
reconfiguration, clinical integration and physician partnering, as well as
evidence-based care process redesign and clinical performance improvement
services.
<PAGE>
APACHE's Health Outcomes Research division provides advanced clinical data
collection tools, registry management and analytic services for federal
government research, as well as in support of clinical trial design and
product-effectiveness evaluations for the pharmaceutical and medical device
industries.
APACHE (www.apache-msi.com) is headquartered in Northern Virginia.
Statements in this press release which are not historical facts are
forward-looking statements under provisions of the Private Securities Litigation
Reform Act of 1995. All forward-looking statements involve risks and
uncertainties. The Company wishes to caution readers that the following
important factors, among others, in some cases have affected, and in the future
could affect, the Company's actual results and could cause its actual results in
fiscal 1999 and beyond to differ materially from those expressed in any
forward-looking statements made by, or on behalf of the Company.
Important factors that could cause actual results to differ materially include
but are not limited to the Company's having sufficient sales and timely
collections to meet cash requirements and achieve profitability; ability to
attract and retain key employees; success of its strategy to concentrate its
product offerings on high-risk, high-cost patients; ability to timely develop
new products and enhance existing products; ability to compete in the
competitive and rapidly evolving healthcare information technology industry;
success of its marketing and consulting efforts and ability to effectively
utilize its direct sales force; ability to protect proprietary information and
to obtain necessary licenses on commercially reasonable terms; and ability to
comply with and adopt products and services to potential regulatory changes.
<PAGE>
